ABT Stock and Options Trade Setup — Abbott Laboratories
NYSE · S&P 500 · Medical Devices & Diagnostics · Moderate-high liquidity options · Large cap · ~$196B
Abbott's FreeStyle Libre CGM franchise is the highest-conviction growth engine in medical devices — global diabetes prevalence is still expanding, CGM penetration is sub-30% even in developed markets, and Abbott commands the cost-access advantage with Libre 3 priced below Dexcom. The combination of recurring sensor revenue (sensors are replaced every 14 days) and expanding insurance reimbursement creates a highly predictable, high-margin annuity. Structural heart devices (TAVR, MitraClip) represent a second growth layer as the aging U.S. population enters peak cardiac intervention years. Abbott successfully lapped the COVID rapid test revenue cliff in 2024 and is now growing organically from a cleaner baseline. Diagnostics and nutrition (Ensure, Similac) provide recession-resistant revenue diversification. The options market is relatively quiet outside earnings, creating consistently favorable IVR conditions for premium-collecting or directional plays.
Score History & Signal Changelog
Preview dataThis page is a living document — updated every 72 hours from the last scan. Each data point below represents one complete algorithmic snapshot.
Signal Breakdown
Today's Trade Card
Options Profile
Risks & Fundamentals
Every setup carries risk. Here's what could move ABT against you, plus the key stats that frame any position.
- 1.Dexcom and Medtronic aggressive CGM pricing competition could compress Libre market share
- 2.Infant formula recall liability risk (historical precedent with Similac) remains a tail risk
- 3.Structural heart device growth dependent on hospital staffing and procedure volume recovery
ABT Options Setup — Frequently Asked Questions
Is ABT a good options trade today?+
Abbott Laboratories (ABT) currently has an Amora Edge Score of 66/100, ranking it top 34% of today's scan. This composite score is built from four sub-signals — EMA cross, RSI zone, relative strength vs SPY, and volume surge — each scored 0–25. The current read is a bullish setup, so the algorithm is positioned bullish (calls / call debit spreads). A score above 65 typically warrants a trade card with stop and target; below that, the setup is on the watchlist but not actionable.
What is ABT's win rate on Stoptions.ai setups?+
ABT's historical win rate on closed Stoptions setups is 64%. Win rate is calculated as the percentage of past ABT trade cards that hit their target price before stopping out. Win rate is most meaningful once a ticker has 10+ closed trades — individual ticker rates can be noisy at smaller samples. Our portfolio-wide win rate across all closed trades is the more stable benchmark.
What strike and expiry does Stoptions.ai suggest for ABT?+
The strike and expiry are shown on the trade card at the top of this page when the setup is active. Stoptions.ai algorithmically selects strikes targeting delta 0.35–0.45 and expirations 30–45 days out, adjusted for current implied volatility rank (IVR). When IVR is high, the system favors call debit spreads to limit vega risk; when IVR is low, single-leg long calls are preferred. The card includes the contract symbol, mid-price entry, stop, and target.
How often is the ABT setup updated?+
Every 72 hours we refresh ABT's Amora Edge Score and trade card. The underlying scan runs daily at 9:00 AM ET (pre-market) and 9:30 AM ET (post-open), so any new signal change is reflected within one trading session. If ABT drops below the entry threshold or the regime shifts (e.g., SPY enters a confirmed bear), the trade card is replaced with a "no setup" notice automatically.
What does the Amora Edge Score measure for ABT?+
The Amora Edge Score is a 0–100 composite of four technical sub-signals applied to ABT: (1) EMA cross — is the 20-day above the 50-day with both trending up? (2) RSI zone — is momentum in the 50–70 sweet spot, or extended/weak? (3) Relative strength vs SPY — is ABT outperforming the market over 20 sessions? (4) Volume surge — is participation above the 20-day average? Each sub-signal contributes 0–25 points. ABT currently scores 66.
How does ABT compare to other Medical Devices & Diagnostics setups?+
ABT's sector rank and percentile against other Medical Devices & Diagnostics tickers we track is shown on the /tickers index — sortable by Amora Edge Score, win rate, or sector. For direct comparison, see the "Related Medical Devices & Diagnostics Options Setups" panel above. When multiple tickers in the same sector are scoring 80+, the algorithm flags the cluster as a sector rotation signal and may upweight position sizing.
Educational content only — not personalized investment advice. Options carry substantial risk.
Get a Friday recap including setups like ABT.
Every Friday at 4:30 PM ET — trade of the week, signals in motion, sector spotlight, methodology read. 4-minute read. Free.
No spam. One email Friday afternoon. Unsubscribe in one click.